Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.

ABSTRACT:

Aims

Bladder cancer (BCa) is a common cancer in North America and Europe that carries considerable morbidity and mortality. A reliable biomarker for early detection of the bladder is crucial for improving the prognosis of BCA. In this meta-analysis, we examine the diagnostic role of the angiogenin (ANG) protein in patients' urine with bladder neoplasm.

Methods

We performed a systematic literature search using ScienceDirect, Web of Science, PubMed/MEDLINE, Scopus, Google Scholar, and Embase, up to 10^th October 2020 databases. Meta-Disc V.1.4 and Comprehensive Meta-Analysis V.2.2 software calculated the pooled specificity, sensitivity, area under the curve (AUC), diagnostic odds ratio (DOR), positive likelihood ratio (LR⁺), negative likelihood ratio (LR

SUBMITTER: Aalami AH 

PROVIDER: S-EPMC8099530 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature